- Sections
- C - Chimiemétallurgie
- C08B - Polysaccharidesleurs dérivés
- C08B 37/04 - Acide alginiqueSes dérivés
Détention brevets de la classe C08B 37/04
Brevets de cette classe: 112
Historique des publications depuis 10 ans
|
2
|
8
|
13
|
4
|
14
|
4
|
9
|
4
|
5
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Mochida Pharmaceutical Co., Ltd. | 335 |
14 |
| Sigilon Therapeutics, Inc. | 111 |
7 |
| The University of Tokyo | 4333 |
5 |
| Seikagaku Corporation | 169 |
4 |
| Massachusetts Institute of Technology | 10204 |
3 |
| Children's Medical Center Corporation | 1941 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 861 |
3 |
| Nuecology Biomedical Inc. | 14 |
3 |
| Dainichiseika Color & Chemicals Mfg. Co., Ltd. | 370 |
2 |
| Shanghai Green Valley Pharmaceutical Co., Ltd. | 31 |
2 |
| Universidad Del Pais VASCO | 76 |
2 |
| Matripharm International Inc. | 10 |
2 |
| Qingdao Bright Moon Seaweed Group | 3 |
2 |
| Kao Corporation | 5056 |
1 |
| Daikin Industries, Ltd. | 10401 |
1 |
| The Johns Hopkins University | 5844 |
1 |
| President and Fellows of Harvard College | 6060 |
1 |
| Adocia | 145 |
1 |
| Algipharma AS | 44 |
1 |
| Bespoke BioScience, LLC | 10 |
1 |
| Autres propriétaires | 53 |